Pre-clinical and clinical evaluation of the malaria vaccines RH5-VLP and PfSPZ vaccine
<p>Despite progress through expanded use of bed nets and anti-malarial drugs, <em>Plasmodium falciparum</em> (Pf) malaria caused about 200 million cases and 500,000 deaths in 2015. An ideal vaccine would reduce the burden of disease and interrupt transmission. Despite decades of ef...
Autor principal: | Ishizuka, A |
---|---|
Altres autors: | Draper, S |
Format: | Thesis |
Publicat: |
2016
|
Ítems similars
-
Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity
per: Bhatia, Sangeeta
Publicat: (2022) -
Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial
per: Zita Sulyok, et al.
Publicat: (2021-05-01) -
A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection
per: Benjamin Mordmüller, et al.
Publicat: (2022-08-01) -
PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial
per: Drissa Coulibaly, et al.
Publicat: (2022-10-01) -
PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adultsResearch in context
per: Anneth Tumbo, et al.
Publicat: (2024-10-01)